相关实验视频
Updated: Feb 24, 2026

10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
10.3K
在以前持续病毒学反应的患者中,晚期型肝炎复发的演变:一项为期18年的前性研究
Wei-Ting Chen1, Yi-Jyun Shen2, Rong-Nan Chien1
1Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan; Department of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Journal of global antimicrobial resistance
|February 22, 2026
概括
晚期型肝炎病毒 (HCV) 复发 (RCI) 很少发生在亚洲患者中,从而达到持续的病毒学反应 (SVR). 隐藏的HCV感染 (OCI) 可能会在RCI之前出现,并使用sophisbuvir/velpatasvir进行成功的再治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 晚期复发性型肝炎病毒 (HCV) 感染 (RCI) 现型在亚洲尚不清楚.
- 持续病毒学反应 (SVR) 是HCV治疗的目标,但可以出现晚期复发.
- 隐性HCV感染 (OCI) 是晚期RCI的一个潜在因素.
研究的目的:
- 调查台湾SVR患者晚期RCI的表型.
- 确定晚期RCI的发生率及其与OCI的关联.
- 评估晚期RCI患者的治疗结果.
主要方法:
- 这是一项长达18年的前性研究,对1004名台湾SVR患者进行了研究.
- 每3-6个月定期跟踪,包括对OCI的评估.
- 在患有异常肝酶或OCI的患者中,晚期RCI评估.
主要成果:
- 在531名患者中,139名患者 (26.1%) 呈OCI阳性.
- 在18年的随访期间,有两名患者 (0.19%) 在晚期RCI中发展.
- 晚期RCI患者中没有一个患有肝硬化或肝细胞癌 (HCC).
结论:
- 晚期RCI是亚洲SVR患者的罕见事件,发生在0.19%的病例中.
- 索福斯布维尔/韦尔帕塔斯维尔在两个晚期RCI患者中成功实现了第二次SVR.
- 需要进一步的研究来澄清OCI,肝脏事件和晚期RCI之间的关系.
相关概念视频
Retrovirus Life Cycles
49.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.9K
Viral Mutations
40.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Hepatic Drug Excretion: Influencing Factors
651
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
651
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
225
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
225
Hepatic Drug Excretion: Enterohepatic Cycling
3.0K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.0K

